D47	Discontinuation and inadequate adherence to pre-exposure prophylaxis of HIV: a systematic review and meta-analysis	E-poster	Monitoring and evaluation of prevention
C32	Discreetness and pain avoidance as central drivers of preferred characteristics in an HIV prevention implant among women in Zimbabwe and South Africa	E-poster	Novel delivery systems (e.g., rings, implants, transdermal systems)
D110	Discrimination response, an alternative forum to resolve grievance	E-poster	Interventions to reduce stigma and discrimination
D33	Disparate HIV viral load suppression rates between rural and urban populations of Uganda from July 2019 through June 2020	E-poster	Scale up of viral load monitoring
C55	Disseminated effects of the initial training and subsequent booster sessions components of the HIV Prevention Trials Network 037 peer-driven intervention on HIV injection risk behavior in people who inject drugs	E-poster	Prevention in people who inject drugs
D76	Distinct forms of population mobility are differentially associated with objectively measured antiretroviral treatment (ART) adherence	E-poster	Migration and HIV
D82	Do childhood and adolescence sexual violence experiences relate to HIV testing and PrEP uptake in young adulthood among MSM of color living in an urban area of the United States?	On-demand oral abstract session	Gay, bisexual, and other men who have sex with men
D2	Does onsite HIV self-testing enhance linkage to care? A case study of HIVST Challenge Fund Project in Kenya	E-poster	Impact evaluation of differentiated service delivery
B24	Does weight gain on Bictegravir/Emtricitabine/Tenofovir Alafenamide (B) lead to metabolic syndrome?	E-poster	Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy)
B24	Dolutegravir-based regimen is associated with metabolic syndrome components among persons with HIV in sub-Saharan Africa	E-poster	Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy)